These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16921196)

  • 21. What glucose target should we aim for in myocardial infarction?
    Cheung NW; Wong VW; McLean M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):411-5. PubMed ID: 18339441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of insulin infusion on electrocardiographic findings following acute myocardial infarction: importance of glycaemic control.
    Gan RM; Wong V; Cheung NW; McLean M
    Diabet Med; 2009 Feb; 26(2):174-6. PubMed ID: 19236622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diabeton in the treatment of stage I nephroangiopathy in insulin-dependent diabetes mellitus].
    Kashirina EP; Bryzgalina SM; Balabolkin MI
    Sov Med; 1991; (1):68-9. PubMed ID: 1862390
    [No Abstract]   [Full Text] [Related]  

  • 24. [Large-scale randomized intervention trial on diabetes in Japan].
    Sone H; Yamada N
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():44-50. PubMed ID: 12430206
    [No Abstract]   [Full Text] [Related]  

  • 25. Is insulin the preferred compound in lowering glucose levels in patients after a myocardial infarction?
    Rensing KL; Kastelein JJ; Twickler M
    Arch Intern Med; 2009 Sep; 169(17):1636-7; author reply 1637-8. PubMed ID: 19786687
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Performance of real-world studies for inhaled insulin].
    Göke B
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S91-4. PubMed ID: 15988676
    [No Abstract]   [Full Text] [Related]  

  • 28. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Intensive insulin regimens in primary prevention should be assessed.
    McLaughlin K
    BMJ; 1997 Aug; 315(7107):544-5. PubMed ID: 9329315
    [No Abstract]   [Full Text] [Related]  

  • 29. Glitazones in type 2 diabetes: an update.
    Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimization of blood glucose control in MI patients: state of the art and a proposed protocol for intensive insulin therapy.
    Monteiro S; Monteiro P; Providência LA
    Rev Port Cardiol; 2009 Jan; 28(1):49-61. PubMed ID: 19388493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetes and myocardial infarction: intensive glucose control important according to international guidelines].
    Norhammar A; Malmberg K; Mellbin L; Rydén L
    Lakartidningen; 2006 Nov 22-28; 103(47):3734, 3737-8; discussion 3738-9. PubMed ID: 17212326
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study.
    Malmberg K
    Endocr Pract; 2004; 10 Suppl 2():13-6. PubMed ID: 15251635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Already in altered glucose tolerance an antidiabetic drug. Significantly fewer heart attacks].
    MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619238
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-insulin-potassium infusion in the management of acute hyperglycemia in patients with ST-segment elevation acute myocardial infarction: lessons learned from randomized trials.
    Celik T
    J Cardiol; 2009 Aug; 54(1):167-8; author reply 168. PubMed ID: 19632540
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate).
    Richter B; Berger M
    Diabetologia; 2000 Apr; 43(4):528-32. PubMed ID: 10819251
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperosmolar hyperglycaemic nonketotic coma associated with acute myocardial infarction: report of three cases.
    Yildiz M; Gül C; Ozbay G
    Acta Cardiol; 2002 Aug; 57(4):271-4. PubMed ID: 12222695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
    Al Shamsi AM
    Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
    [No Abstract]   [Full Text] [Related]  

  • 40. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
    Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
    Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.